Biden and Sanders Demand Lower Prices for Popular Weight-Loss Drugs

The President and Senator criticize pharmaceutical giants Novo Nordisk and Eli Lilly for charging Americans significantly more than other countries.

Shares of Novo Nordisk and Eli Lilly fell after Biden and Sanders' op-ed in USA Today.
The op-ed calls for substantial price reductions on drugs like Ozempic, Wegovy, and Mounjaro.
Biden and Sanders argue that high drug prices in the U.S. are unjustified and driven by corporate greed.
The Inflation Reduction Act has already capped insulin prices and allowed Medicare to negotiate some drug prices.
Legislation is being proposed to expand price negotiation to more drugs and extend benefits beyond Medicare.